Taipei, June 10 (CNA) Taiwan's Food and Drug Administration (FDA) on Thursday made public its standards in granting emergency use authorizations (EUA) for locally developed COVID-19 vaccines, with one requirement being that the domestic vaccine candidates have to offer at least the same level of protection as that of the AstraZeneca (AZ) vaccine.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
Young boxing league breathes new life into Taiwan sport scene
03/28/2024 04:52 PM - Business
U.S. dollar closes lower on Taipei forex market
03/28/2024 04:17 PM - Society
Bongkrek acid suspected in deadly Taipei food poisoning outbreak
03/28/2024 02:42 PM - Business
Taiwan's economy remains stable on improving exports, production
03/28/2024 02:27 PM - Business
Taiwan shares close down 0.27%
03/28/2024 02:06 PM